23andMe and Its Customers' Data Sold to US Pharma Giant

DNA Giant 23andMe To Be Acquired After Bankruptcy

Source: Anadolu / Getty On Monday (May 19), the biotech giant Regeneron  Pharmeceuticals announced that they were acquiring the DNA testing company 23andMe after it was up for sale in an auction after declaring bankruptcy. Regeneron is best known for its antibody drug cocktail which was used by President Donald Trump when he fell ill with COVID-19 during his first term. 23andMe was a dominant product as genetic testing became more publicly accep…

Regeneron Acquires DNA Of Americans & Other Health News

If you were one of the millions of Americans who used 23andMe to analyze your DNA for ancestry and health predispositions, the bankrupt company has now been acquired by Regeneron, a pharmaceutical company who developed monoclonal antibodies as a CONvid-1984 treatment. Now, Regeneron, having access to millions of Americans’ DNA samples, will be using your …

Massive Pharmaceutical Company Set to Acquire '23 And Me' And It's Genetic Data

Regeneron Pharmaceuticals is buying personal genomics company 23andMe for $256 million following a bankruptcy auction. This move gives Regeneron access to one of the largest private genetic databases in the world—raising big questions about privacy, purpose, and profit. Key Facts: Regeneron Pharmaceuticals won the bankruptcy auction for 23andMe with a $256 million bid. 23andMe houses genetic data from over 15 million people in its Biobank. Over…

23andMe Found a Buyer for Our Genetic Data, and I’m Kind of Optimistic

Before, we told you to delete your data because 23andMe was about to be sold. Now, a buyer has been announced, and they’re promising to “prioritize the privacy, security and ethical use” of customer data, and to keep offering the company’s services uninterrupted. This is all—probably—good news.

23andMe sale: What will happen to the DNA data under Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is acquiring 23andMe and says it will use the DNA data for drug development.

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

Link URL: https://www.marketwatch.com/story/23andme-sells-its-most-valuable-asset-regeneron-promises-keep-your-dna-private-d8065fc7 Comments URL: https://tildes.net/~finance/1o3c/23andme_sells_its_most_valuable_asset_to_biotech_company_regeneron_which_promises_to_keep_your_dna Votes: 32 Comments: 17